S Liekens

Heparin derivatives as angiogenesis inhibitors.

M. Rusnati, M. Presta, R. Ronca, 2003, Current pharmaceutical design.

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.

R. Esnouf, E. De Clercq, J. Neyts, 1999, Molecular pharmacology.